What does CUSIP 868459108 represent in this 13F holders report?

CUSIP 868459108 is the security identifier for SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock in Q2 2017?

262 institutional investors reported SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock for Q2 2017. Use the holders table for investor-level position and value details.

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

CUSIP: 868459108

Q2 2017 13F Holders as of 30 Jun 2017

Security type / class: Equity / Common Stock
Shares outstanding: 57,671,650
Total 13F shares: 47,330,397
Share change: +2,243,311
Total reported value: $2,039,414,220
Put/Call ratio: 64%
Reported price per share: $43.10
Number of holders: 262
Value change: +$105,035,296
Number of buys: 142
Number of sells: 119

Security key

868459108

Report period

Q2 2017

Institutions

262

Top holders

SUPN full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2017 Previous quarter: Q1 2017 SUPERNUS PHARMACEUTICALS, INC. SEC filings SUPERNUS PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 868459108

Newer quarter: Q3 2017 Previous quarter: Q1 2017

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

BlackRock Finance, Inc.

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2017

13F Lead comparable stake: 12% Showing first 8 of 50 holder rows. Open remaining rows

Rank 1 holder

BlackRock Finance, Inc.

13F

Ownership: 12%
Position: $209.6M

13F

Rank 2 holder

VANGUARD GROUP INC

13F

Ownership: 4.4%
Position: $78.76M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
BlackRock Finance, Inc.	13F Company 13F	12%	$209,595,000 6,696,310 shares	—	31 Mar 2017
VANGUARD GROUP INC	13F Company 13F	4.4%	$78,762,000 2,516,335 shares	—	31 Mar 2017
Bank of New York Mellon Corp	13F Company 13F	2.9%	$52,236,000 1,668,863 shares	—	31 Mar 2017
Invesco Ltd.	13F Company 13F	2.9%	$51,946,000 1,659,594 shares	—	31 Mar 2017
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	2.8%	$50,732,000 1,620,798 shares	—	31 Mar 2017
Ranger Investment Management, L.P.	13F Company 13F	2.6%	$46,403,000 1,482,535 shares	—	31 Mar 2017
STATE STREET CORP	13F Company 13F	2.4%	$42,422,000 1,355,319 shares	—	31 Mar 2017
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	2%	$35,871,000 1,146,040 shares	—	31 Mar 2017

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F Company 13F	2%	$35,365,000 1,129,858 shares	—	31 Mar 2017
RICE HALL JAMES & ASSOCIATES, LLC	13F Company 13F	1.9%	$34,223,000 1,093,402 shares	—	31 Mar 2017
GLENMEDE TRUST CO NA	13F Company 13F	1.9%	$33,514,000 1,073,335 shares	—	31 Mar 2017
Fiera Capital Corp	13F Company 13F	1.7%	$31,186,000 996,362 shares	—	31 Mar 2017
NEUMEIER POMA INVESTMENT COUNSEL LLC	13F Company 13F	1.5%	$27,429,000 876,310 shares	—	31 Mar 2017
Russell Investments Group, Ltd.	13F Company 13F	1.5%	$27,421,000 876,040 shares	—	31 Mar 2017
ASHFORD CAPITAL MANAGEMENT INC	13F Company 13F	1.3%	$23,307,000 744,634 shares	—	31 Mar 2017
LOOMIS SAYLES & CO L P	13F Company 13F	1.2%	$21,617,000 690,624 shares	—	31 Mar 2017
NORTHERN TRUST CORP	13F Company 13F	1.1%	$19,889,000 635,426 shares	—	31 Mar 2017
AMERIPRISE FINANCIAL INC	13F Company 13F	1.1%	$19,230,000 614,419 shares	—	31 Mar 2017
PRICE T ROWE ASSOCIATES INC /MD/	13F Company 13F	1%	$18,306,000 584,861 shares	—	31 Mar 2017
MILLENNIUM MANAGEMENT LLC	13F Company 13F	0.99%	$17,933,000 572,938 shares	—	31 Mar 2017
Allianz Asset Management GmbH	13F Company 13F	0.94%	$16,938,000 541,158 shares	—	31 Mar 2017
Polar Capital LLP	13F Company 13F	0.91%	$16,433,000 525,000 shares	—	31 Mar 2017
WELLS FARGO & COMPANY/MN	13F Company 13F	0.89%	$16,057,000 513,009 shares	—	31 Mar 2017
FALCON POINT CAPITAL, LLC	13F Company 13F	0.85%	$15,266,000 487,717 shares	—	31 Mar 2017
Granite Investment Partners, LLC	13F Company 13F	0.82%	$14,736,000 470,799 shares	—	31 Mar 2017
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F Company 13F	0.81%	$14,681,000 469,044 shares	—	31 Mar 2017
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	0.78%	$14,015,000 447,824 shares	—	31 Mar 2017
TEACHERS ADVISORS, LLC	13F Company 13F	0.76%	$13,651,000 436,121 shares	—	31 Mar 2017
NORTHPOINTE CAPITAL LLC	13F Company 13F	0.74%	$13,334,000 425,997 shares	—	31 Mar 2017
PRINCIPAL FINANCIAL GROUP INC	13F Company 13F	0.71%	$12,809,000 409,242 shares	—	31 Mar 2017
KORNITZER CAPITAL MANAGEMENT INC /KS	13F Company 13F	0.7%	$12,596,000 402,435 shares	—	31 Mar 2017
EVENTIDE ASSET MANAGEMENT, LLC	13F Company 13F	0.64%	$11,581,000 370,000 shares	—	31 Mar 2017
BANK OF AMERICA CORP /DE/	13F Company 13F	0.63%	$11,361,000 362,952 shares	—	31 Mar 2017
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F Company 13F	0.62%	$11,259,000 359,739 shares	—	31 Mar 2017
MORGAN STANLEY	13F Company 13F	0.61%	$10,932,000 349,275 shares	—	31 Mar 2017
PANAGORA ASSET MANAGEMENT INC	13F Company 13F	0.53%	$9,629,000 307,640 shares	—	31 Mar 2017
NEW YORK STATE COMMON RETIREMENT FUND	13F Company 13F	0.52%	$9,410,000 300,630 shares	—	31 Mar 2017
AMERICAN CENTURY COMPANIES INC	13F Company 13F	0.5%	$8,941,000 285,664 shares	—	31 Mar 2017
CASTLEARK MANAGEMENT LLC	13F Company 13F	0.49%	$8,798,000 281,091 shares	—	31 Mar 2017
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F Company 13F	0.48%	$8,723,000 278,685 shares	—	31 Mar 2017
PNC FINANCIAL SERVICES GROUP, INC.	13F Company 13F	0.41%	$7,417,000 236,974 shares	—	31 Mar 2017
Rhenman & Partners Asset Management AB	13F Company 13F	0.4%	$7,199,000 230,000 shares	—	31 Mar 2017
AlphaOne Investment Services, LLC	13F Company 13F	0.39%	$7,118,000 227,437 shares	—	31 Mar 2017
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	0.39%	$7,070,000 225,905 shares	—	31 Mar 2017
PRUDENTIAL FINANCIAL INC	13F Company 13F	0.39%	$7,048,000 225,190 shares	—	31 Mar 2017
TIAA CREF INVESTMENT MANAGEMENT LLC	13F Company 13F	0.39%	$7,040,000 224,934 shares	—	31 Mar 2017
AXA S.A.	13F Company 13F	0.36%	$6,519,000 208,270 shares	—	31 Mar 2017
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F Company 13F	0.35%	$6,250,000 200,000 shares	—	31 Mar 2017
SEI INVESTMENTS CO	13F Company 13F	0.35%	$6,253,000 199,782 shares	—	31 Mar 2017
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.34%	$6,113,000 195,279 shares	—	31 Mar 2017

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

262

47,330,397

Rows loaded

262

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

244

Q2 2017 holders

262

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 value	Q2 2017 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN)

Q2 2017 13F Holders as of 30 Jun 2017

Holder history for CUSIP 868459108

Top shareholders of SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

BlackRock Finance, Inc.

VANGUARD GROUP INC

Bank of New York Mellon Corp

Institutional holders as of Q2 2017

Compare Q2 2017 vs Q1 2017 Across Filers